What can we help you find?
Pharmacy Aims to Serve LGBTQ Communities
TIN Rx is aiming to serve the most vulnerable populations, including LGBTQ patients, homeless patients, and others who may typically face stigma in pharmacies.
Trending News Today: California Pharmacists Can Now Dispense PrEP Without Prescriptions
Top news of the day from across the health care landscape.
FDA Approves New PrEP Drug
The FDA has approved emtricitabine 200 mg and tenofovir alafenamide 25 mg (Descovy, Gilead Sciences Inc.) as a second pre-exposure prophylaxis drug in at-risk adults and adolescents weighing at least 75 Ib.
London Mayor Calls for Broader Access to PrEP at Global HIV Conference
London Mayor Sadiq Khan has called for broader availability of pre-exposure prophylaxis drugs in his welcoming speech at the Fast-Track Cities 2019 conference, where leaders from 300 cities around the world will discuss municipal responses to HIV, tuberculosis, and viral hepatitis.
California Appropriations Committee to Discuss PrEP Bill
In recent months, legislation to increase access to pre- and post-exposure prophylaxis (PrEP and PEP) passed in California with a vote of 34-1 in the Senate and a unanimous vote in the Assembly. 
A New PrEP Drug Could Be On the Horizon
An FDA committee has recommended approval of Gilead’s Descovy to reduce the risk of sexually acquired HIV infection in those at high risk of acquiring the virus.
FDA Committee Recommends Approval of Descovy for HIV PrEP Indication
An FDA committee voted 16 to 2 to recommended emitricitabine 200 mg and tenofovir alafenamide 25 mg tablets (Descovy, Gilead) for a HIV pre-exposure prophylaxis indication.
Study: PrEP Awareness and Use Is Increasing
Pre-exposure prophylaxis (PrEP) can reduce the risk of HIV infection in individuals at high risk.
Trending News Today: New PrEP Approach Reduces Number of Pills Needed
Top news of the day from across the health care landscape.
Early Data Present HIV Drug as Potential Once-Yearly PrEP Option Using Implant Delivery
Administered through a drug-eluting implant, islatravir demonstrated protection against HIV for up to 12 months.
Trending News Today: PrEP Use Among Urban MSM Increasing, But Many Still Lack Access
Top news of the day from across the health care landscape.
Targeting HIV Transmission Rates
Health care professionals, including pharmacists and nurse practitioners, play a critical role in attaining goals for reducing HIV transmission. 
+ Load More